Page 24 - Coronary hemodynamics in acute myocardial infarction - Matthijs Bax

Chapter 1
References
1. Reimer KA and Jennings RB. The “wavefront phenomenon” of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest. 1979;40:633-44.
2. Bata IR, Gregor RD, Wolf HK and Brownell B. Trends in five-year survival of patients discharged after acute myocardial infarction. Can J Cardiol. 2006;22:399-404.
3. Dorresteijn JA, Visseren FL, Wassink AM, Gondrie MJ, Steyerberg EW, Ridker PM, Cook NR and van der Graaf Y. Development and validation of a prediction rule for recurrent vascular events based on a cohort study of patients with arterial disease: the SMART risk score. Heart. 2013;99:866-72.
4. Law MR, Watt HC and Wald NJ. The underlying risk of death after myocardial infarction in the absence of treatment. Arch Intern Med. 2002;162:2405-10.
5. Stone SG, Serrao GW, Mehran R, Tomey MI, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Mockel M, Brener SJ, Dangas G and Stone GW. Incidence, predictors, and implications of reinfarction after primary percutaneous coronary intervention in ST-segment-elevation myocardial infarction: the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial. Circ Cardiovasc Interv. 2014;7:543-51.
6. Julian DG, Valentine PA and Miller GG. Disturbances of Rate, Rhythm and Conduction in Acute Myocardial Infarction: A Prospective Study of 100 Consecutive Unselected Patients with the Aid of Electrocardiographic Monitoring. Am J Med. 1964;37:915-27.
7. Simoons ML, Serruys PW, vd Brand M, Bar F, de Zwaan C, Res J, Verheugt FW, Krauss XH, Remme WJ, Vermeer F and et al. Improved survival after early thrombolysis in acute myocardial infarction. A randomised trial by the Interuniversity Cardiology Institute in The Netherlands. Lancet. 1985;2:578- 82.
8. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. J Am Coll Cardiol. 1988;12:3A-13A.
9. Hartzler GO, Rutherford BD, McConahay DR, Johnson WL, Jr., McCallister BD, Gura GM, Jr., Conn RC and Crockett JE. Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction. Am Heart J. 1983;106:965-73.
10. Zijlstra F, Hoorntje JC, de Boer MJ, Reiffers S, Miedema K, Ottervanger JP, van ‘t Hof AW and Suryapranata H. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 1999;341:1413-9.
11. De Luca G, Suryapranata H, Ottervanger JP and Antman EM. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation. 2004;109:1223-5.
12. Davies MJ and Thomas AC. Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J. 1985;53:363-73.
13. Arbustini E, Dal Bello B, Morbini P, Burke AP, Bocciarelli M, Specchia G and Virmani R. Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction. Heart. 1999;82:269-72.
14. Schachinger V, Britten MB and Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 2000;101:1899-906.
15. Fichtlscherer S, Breuer S and Zeiher AM. Prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes: further evidence for the existence of the “vulnerable” patient. Circulation. 2004;110:1926-32.
16. Falk E and Thuesen L. Pathology of coronary microembolisation and no reflow. Heart. 2003;89:983- 5.
17. Jennings RB, Sommers HM, Smyth GA, Flack HA and Linn H. Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog. Arch Pathol. 1960;70:68-78.
18. Jennings RB, Ganote CE, Kloner RA, Whalen DA, Jr. and Hamilton DG. Explosive swelling of myocardial cells irreversibly injured by transient ischemia. Recent Adv Stud Cardiac Struct Metab. 1975;6:405-13.
22